Quantitative Analysis of the Activity in Choroidal Neovascularizations after a Single Anti-VEGF Injection: OCT Versus OCT Angiography
dc.contributor.author | Altinisik M. | |
dc.contributor.author | Kurt E. | |
dc.contributor.author | Kayikcioglu O. | |
dc.contributor.author | Yildirim A. | |
dc.date.accessioned | 2024-07-22T08:06:35Z | |
dc.date.available | 2024-07-22T08:06:35Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Purpose: To analyze early quantitative changes in the choroidal neovascularization (CNV) area observed with optical coherence tomography angiography (OCTA) after single anti-vascular endothelial growth factor (anti-VEGF) injection. Materials and Methods: Treatment-naive patients with CNV secondary to neovascular age-related macular degeneration were analyzed immediately before and ~4 weeks after anti-VEGF injection. The primary endpoints of the study included changes in CNV total and vascular area. Secondary endpoints were best-corrected visual acuity (BCVA), central macular thickness (cMT), central total macular thickness (cTMT), and subfoveal choroidal thickness (SFCT). Results: A total of 27 patients (69.19 ± 5.91 years, 21 men/6 women, 14 type 1 NV, 11 type 2 NV, and 2 type 3 NV) were included in the study. There was a significant increase in BCVA and decreases in cMT, cTMT, and SFCT after treatment (p<0.05 for all). CNV total and vascular area changed by −11.55 ± 44.26% (95% confidence interval [CI]: −29.06 and 5.95; p=0.269) and −21.06 ± 41.2% (95% CI: −36.45/−5.67; p=0.786), respectively. The cases with decreased cTMT were accompanied by a decrease in CNV area only in 37% of the cases. No significant correlation was detected between cTMT and CNV total and vascular area percentage changes (r = −0.06, p=0.74; r = 0.02, p=0.9, respectively). Conclusions: Changes in CNV total and vascular area seem to have limited sensitivity as a biomarker in terms of activation, as wide variability was observed in CNV area after anti-VEGF injection. © 2021 Taylor & Francis. | |
dc.identifier.DOI-ID | 10.1080/08820538.2021.1903944 | |
dc.identifier.issn | 08820538 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13592 | |
dc.language.iso | English | |
dc.publisher | Taylor and Francis Ltd. | |
dc.subject | Angiogenesis Inhibitors | |
dc.subject | Choroidal Neovascularization | |
dc.subject | Female | |
dc.subject | Fluorescein Angiography | |
dc.subject | Humans | |
dc.subject | Infant | |
dc.subject | Infant, Newborn | |
dc.subject | Intravitreal Injections | |
dc.subject | Male | |
dc.subject | Retrospective Studies | |
dc.subject | Tomography, Optical Coherence | |
dc.subject | Visual Acuity | |
dc.subject | bevacizumab | |
dc.subject | dexamethasone | |
dc.subject | netilmicin | |
dc.subject | tropicamide | |
dc.subject | angiogenesis inhibitor | |
dc.subject | aged | |
dc.subject | Article | |
dc.subject | best corrected visual acuity | |
dc.subject | cataract extraction | |
dc.subject | central macular thickness | |
dc.subject | clinical article | |
dc.subject | comparative study | |
dc.subject | confidence interval | |
dc.subject | controlled study | |
dc.subject | diabetic retinopathy | |
dc.subject | eye surgery | |
dc.subject | female | |
dc.subject | follow up | |
dc.subject | human | |
dc.subject | male | |
dc.subject | observational study | |
dc.subject | optical coherence tomography angiography | |
dc.subject | patient referral | |
dc.subject | photodynamic therapy | |
dc.subject | prospective study | |
dc.subject | quantitative analysis | |
dc.subject | retina vein occlusion | |
dc.subject | retinal pigment epithelium | |
dc.subject | subfoveal choroidal thickness | |
dc.subject | subretinal fluid | |
dc.subject | subretinal neovascularization | |
dc.subject | fluorescence angiography | |
dc.subject | infant | |
dc.subject | intravitreal drug administration | |
dc.subject | newborn | |
dc.subject | optical coherence tomography | |
dc.subject | retrospective study | |
dc.subject | subretinal neovascularization | |
dc.subject | visual acuity | |
dc.title | Quantitative Analysis of the Activity in Choroidal Neovascularizations after a Single Anti-VEGF Injection: OCT Versus OCT Angiography | |
dc.type | Article |